Recall intervals in supportive periodontal therapy

Maintenance frequency is not fixed: it follows individual progression risk and is adjusted for diagnosis and stability. This guide explains the logic used by the calculator.

Why personalise recalls

In SPT, overly long intervals in high-risk patients favour relapse and tooth loss; unnecessarily short intervals in low-risk patients increase burden without clear benefit. The goal is to align interval with PRA risk and diagnostic complexity.

Maintenance literature shows that sites with residual pockets and persistent inflammation are the ones that most often progress when recalls stretch. Personalising does not mean “see everyone every three months”; it means reserving high frequency for those who need it clinically and freeing chair time for stable low-risk patients.

Baseline from PRA risk

• Low risk → 6–12 months
• Moderate risk → 4–6 months
• High risk → 2–3 months

These ranges are the starting point. Choose within the band based on compliance, hygiene and context.

Adjustments used by the tool

The calculator shortens (caps) the interval when unfavourable prognostic factors coexist:

• Stage IV → maximum 4 months
• Grade C → maximum 4 months
• Post-treatment instability → maximum 3 months

Example: low PRA might suggest 6–12 months, but with Grade C the proposed interval does not exceed 4 months.

Post-treatment stability (2018 consensus)

• Stable: BOP <10%, PD ≤4 mm, no 4 mm site with BOP, no progressive bone loss
• In remission/control: BOP ≥10% but PD ≤4 mm and no 4 mm sites with BOP
• Unstable: PD ≥5 mm, or ≥4 mm with BOP, or progressive bone loss

Instability is not only a diagnostic label: in the tool it lowers the maximum recall interval.

Practical chairside workflow

1. Update relevant clinical and radiographic parameters.
2. Compute stage/grade and PRA.
3. Assess stability.
4. Read the proposed interval and adapt to patient compliance.
5. Document and repeat at every supportive visit.

Talking with patients

Framing the interval in risk terms improves adherence: “your profile today needs 3-month reviews because deep pockets remain / you smoke / diabetes is not at target,” or “risk is low and stable, so we can space visits to 6–12 months.” Transparency reduces the sense that recalls are arbitrary.

When Stage IV or Grade C shortens the interval, link the decision to tooth prognosis and prevention of further loss — not merely to “a cleaning.” Patients grasp the diagnosis–frequency link more clearly.

Special situations

• Implant patients: apply the same risk logic for mucositis/peri-implantitis and keep tight recalls if PRA is high or stability is poor.
• Adolescents / molar–incisor pattern: reassess often; progression can be rapid even with few involved sites.
• Limited access: if 2–3 month visits are impossible, intensify home care, antiseptics when indicated, and catch-up plans as soon as feasible — do not quietly dilute documented risk.

Always document the proposed interval and the one agreed with the patient. If they diverge (work, cost, travel), record why: if disease progresses it will be clear whether the protocol was inadequate or adherence was incomplete. The calculator supplies the clinical baseline; the chart records operational reality.

Reassess the interval not only when the picture worsens, but also when it improves stably across several visits: lengthening recalls in low risk is part of personalisation, not an arbitrary “reward.”

Frequently asked questions

Is the interval an absolute prescription?

No. It is decision support. Compliance, access and patient preferences remain part of professional judgement.

Can I lengthen recalls if the patient looks well?

Only after recalculating risk and stability. Low BOP alone is not enough if deep pockets or Grade C remain.

What if the patient misses appointments?

Treat compliance as a clinical risk factor: shorter intervals, proactive recalls and motivational reinforcement — not simply “come back in a year”.

This guide does not replace a specialist examination. It is clinical decision support, to be interpreted within professional judgement.

Scientific references

1. Lang NP, Tonetti MS. Periodontal risk assessment (PRA) for patients in supportive periodontal therapy (SPT). Oral Health Prev Dent. 2003;1(1):7-16. PubMed
2. Trombelli L, et al. Supportive periodontal therapy. J Clin Periodontol. 2015;42 Suppl 16:S161-S170.
3. Matuliene G, et al. Influence of residual pockets on progression of periodontitis and tooth loss. J Clin Periodontol. 2008;35(8):685-695. PubMed

Clinical guide by Dr. Ernesto Bruschi — bonebenders.com

Last clinical review: 1 August 2026